Insider Trading activities of Trimeris Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Trimeris Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Trimeris Inc since year 2005. Table 2 shows the detailed insider transactions of Trimeris Inc since 2005. The reporting company's ticker symbol is GEVA. The reporting company's CIK number is 911326.
The total value of stock buying since 2005 is $587,024,127.
The total value of stock sales since 2005 is $120,369,219.
The total value of stock option exercises since 2005 is $13,673,582.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Trimeris Inc (GEVA).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2015-06 0 $0 12,916 $2,779,781 12,916 $767,339
2015-05 0 $0 1,666 $345,671 1,666 $81,534
2015-04 0 $0 102,135 $10,092,172 82,135 $2,720,489
2015-03 0 $0 7,500 $772,672 7,500 $305,550
2015-02 0 $0 42,297 $4,242,938 42,297 $897,542
2015-01 2,000,000 $188,380,000 0 $0 0 $0
2014-12 0 $0 56,100 $4,960,229 56,100 $545,685
2014-10 0 $0 25,404 $2,034,839 25,404 $313,739
2014-09 0 $0 24,369 $1,647,569 24,369 $355,440
2014-06 0 $0 25,672 $2,114,184 55,422 $1,990,488
2014-05 0 $0 9,927 $820,367 9,927 $16,875
2014-04 0 $0 20,000 $1,683,899 96,000 $3,904,099
2014-03 750,000 $79,312,500 7,670 $752,480 7,670 $65,578
2014-02 0 $0 9,927 $1,013,864 9,927 $16,875
2014-01 0 $0 102,300 $9,109,059 102,300 $285,000
2013-12 0 $0 7,000 $425,285 7,000 $61,110
2013-11 0 $0 16,927 $903,605 16,927 $77,985
2013-10 0 $0 7,000 $450,030 7,000 $61,110
2013-09 2,100,000 $118,923,000 0 $0 0 $0
2013-08 0 $0 18,781 $886,309 18,781 $257,303
2013-07 0 $0 115,761 $5,553,857 115,761 $255,993
2013-06 0 $0 70,000 $2,845,754 70,000 $81,631
2013-04 0 $0 74,416 $3,796,256 74,416 $70,693
2013-03 0 $0 4,417 $224,692 4,417 $4,196
2013-02 0 $0 70,000 $3,444,318 70,000 $66,499
2013-01 1,740,479 $82,724,965 29,344 $1,448,638 24,344 $30,570
2012-12 0 $0 129,000 $6,156,618 129,000 $122,549
2012-11 0 $0 5,000 $244,325 5,000 $4,750
2012-10 0 $0 13,927 $700,360 13,927 $22,175
2012-09 0 $0 55,813 $2,754,570 55,813 $53,022
2012-08 0 $0 15,187 $757,512 15,187 $14,427
2012-07 1,845,000 $76,014,000 65,818 $3,099,194 16,618 $20,750
2012-06 0 $0 419,278 $16,462,244 51,000 $48,449
2012-05 0 $0 39,709 $1,528,399 39,709 $67,505
2012-04 0 $0 13,000 $516,899 0 $0
2012-03 0 $0 392,278 $12,817,548 50,000 $47,500
2012-02 0 $0 140,500 $5,178,643 4,500 $4,275
2012-01 1,200,000 $30,216,000 0 $0 0 $0
2011-12 0 $0 0 $0 13,200 $29,502
2011-08 80,000 $177,410 8,100 $16,430 0 $0
2010-09 28,216 $69,185 0 $0 0 $0
2009-10 0 $0 2,136,858 $7,551,656 0 $0
2008-12 0 $0 54,268 $137,569 0 $0
2008-03 463,657 $2,883,946 0 $0 0 $0
2007-10 54,410 $423,255 0 $0 0 $0
2007-09 479,336 $3,495,570 0 $0 0 $0
2007-08 303,133 $2,120,592 0 $0 0 $0
2007-05 0 $0 5,616 $40,098 0 $0
2007-02 0 $0 0 $0 3,530 $1,200
2006-03 0 $0 0 $0 7,153 $2,432
2006-02 0 $0 2,009 $24,108 2,009 $683
2006-01 0 $0 3,060 $34,578 3,060 $1,040
2005-12 300 $3,598 0 $0 0 $0
2005-09 197,600 $2,280,106 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Trimeris Inc insiders (GEVA)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2015-06-08 Williams Glen (SVP, Technical Operations) Sale 12,916 215.22 2,779,781
2015-06-08 Williams Glen (SVP, Technical Operations) Option Ex 12,916 59.41 767,339
2015-05-06 Williams Glen (SVP, Technical Operations) Sale 1,666 207.49 345,671
2015-05-06 Williams Glen (SVP, Technical Operations) Option Ex 1,666 48.94 81,534
2015-04-27 Quinn Anthony (EVP, CMO & Head of R&D) Sale 10,000 110.00 1,100,000
2015-04-27 Quinn Anthony (EVP, CMO & Head of R&D) Option Ex 10,000 1.70 17,000
2015-04-21 Quinn Anthony (EVP, CMO & Head of R&D) Sale 10,000 108.00 1,080,000
2015-04-15 Quinn Anthony (EVP, CMO & Head of R&D) Sale 10,000 105.00 1,050,000
2015-04-15 Quinn Anthony (EVP, CMO & Head of R&D) Option Ex 10,000 40.74 407,400
2015-04-08 Williams Glen (SVP, Technical Operations) Sale 39,863 96.08 3,830,037
2015-04-08 Williams Glen (SVP, Technical Operations) Option Ex 39,863 48.94 1,950,895
2015-04-07 Williams Glen (SVP, Technical Operations) Sale 2,769 96.04 265,934
2015-04-07 Williams Glen (SVP, Technical Operations) Option Ex 2,769 40.32 111,646
2015-04-06 Quinn Anthony (EVP, CMO & Head of R&D) Sale 29,503 93.76 2,766,201
2015-04-06 Quinn Anthony (EVP, CMO & Head of R&D) Option Ex 19,503 11.98 233,548
2015-03-11 Heberlig Chris (SVP, Finance and Business Ops.) Sale 7,500 103.02 772,672
2015-03-11 Heberlig Chris (SVP, Finance and Business Ops.) Option Ex 7,500 40.74 305,550
2015-02-17 Boess Carsten (SVP, Chief Financial Officer) Sale 42,297 100.31 4,242,938
2015-02-17 Boess Carsten (SVP, Chief Financial Officer) Option Ex 42,297 21.22 897,542
2015-01-07 Baker Bros. Advisors (gp) Llc (Director) Buy 1,000,000 94.19 94,190,000
2015-01-07 Baker Felix (Director) Buy 1,000,000 94.19 94,190,000
2014-12-29 Heberlig Chris (Group Vice President, Finance) Sale 6,100 91.60 558,729
2014-12-29 Heberlig Chris (Group Vice President, Finance) Option Ex 6,100 12.35 75,335
2014-12-17 Patel Sanj K (President & CEO) Sale 50,000 88.03 4,401,500
2014-12-17 Patel Sanj K (President & CEO) Option Ex 50,000 9.41 470,350
2014-10-30 Boess Carsten (SVP, Chief Financial Officer) Sale 22,904 80.11 1,834,839
2014-10-30 Boess Carsten (SVP, Chief Financial Officer) Option Ex 22,904 12.35 282,864
2014-10-28 Boess Carsten (SVP, Chief Financial Officer) Sale 2,500 80.00 200,000
2014-10-28 Boess Carsten (SVP, Chief Financial Officer) Option Ex 2,500 12.35 30,875
2014-09-19 Goldberg Mark Alan (EVP, Medical & Reg. Strategy) Sale 790 65.24 51,539
2014-09-19 Goldberg Mark Alan (EVP, Medical & Reg. Strategy) Option Ex 790 8.73 6,896
2014-09-17 Goldberg Mark Alan (EVP, Medical & Reg. Strategy) Sale 4,200 65.06 273,252
2014-09-17 Goldberg Mark Alan (EVP, Medical & Reg. Strategy) Option Ex 4,200 8.73 36,666
2014-09-16 Goldberg Mark Alan (EVP, Medical & Reg. Strategy) Sale 9,379 65.01 609,728
2014-09-16 Goldberg Mark Alan (EVP, Medical & Reg. Strategy) Option Ex 9,379 8.73 81,878
2014-09-02 Quinn Anthony (EVP, CMO & Head of R&D) Sale 10,000 71.30 713,050
2014-09-02 Quinn Anthony (EVP, CMO & Head of R&D) Option Ex 10,000 23.00 230,000
2014-06-25 Williams Glen (SVP, Technical Operations) Sale 700 108.02 75,614
2014-06-25 Williams Glen (SVP, Technical Operations) Option Ex 700 48.94 34,258
2014-06-20 Quart Barry D Sale 1,375 100.00 137,500
2014-06-20 Quart Barry D Option Ex 1,375 25.00 34,375
2014-06-20 Baker Bros. Advisors Lp (Director) Option Ex 29,750 60.45 1,798,387
2014-06-17 Quart Barry D Sale 1,000 90.00 90,000
2014-06-17 Quart Barry D Option Ex 1,000 23.95 23,950
2014-06-12 Quart Barry D Sale 1,000 83.31 83,310
2014-06-12 Quart Barry D Option Ex 1,000 23.00 23,000
2014-06-11 Goldberg Mark Alan (EVP, Medical & Reg. Strategy) Sale 21,597 80.00 1,727,760
2014-06-11 Goldberg Mark Alan (EVP, Medical & Reg. Strategy) Option Ex 21,597 3.54 76,518
2014-05-16 Boess Carsten (SVP, Chief Financial Officer) Sale 9,927 82.64 820,367
2014-05-16 Boess Carsten (SVP, Chief Financial Officer) Option Ex 9,927 1.70 16,875
2014-04-23 Baker Bros. Advisors Lp (Director) Option Ex 56,000 65.10 3,645,599
2014-04-01 Quinn Anthony (EVP, CMO & Head of R&D) Sale 20,000 84.20 1,683,899
2014-04-01 Quinn Anthony (EVP, CMO & Head of R&D) Option Ex 30,000 6.46 249,000
2014-03-12 Heberlig Chris (Group Vice President, Finance) Sale 7,670 98.11 752,480
2014-03-12 Heberlig Chris (Group Vice President, Finance) Option Ex 7,670 8.55 65,578
2014-03-06 14159, L.p. (Director) Buy 375,000 105.75 39,656,250
2014-03-06 Baker Felix (Director) Buy 375,000 105.75 39,656,250
2014-02-18 Boess Carsten (SVP, Chief Financial Officer) Sale 9,927 102.13 1,013,864
2014-02-18 Boess Carsten (SVP, Chief Financial Officer) Option Ex 9,927 1.70 16,875
2014-01-29 Patel Sanj K (President & CEO) Sale 50,971 89.44 4,558,846
2014-01-29 Patel Sanj K (President & CEO) Option Ex 50,971 3.52 179,417
2014-01-28 Patel Sanj K (President & CEO) Sale 51,329 88.65 4,550,213
2014-01-28 Patel Sanj K (President & CEO) Option Ex 51,329 2.06 105,583
2013-12-03 Goldberg Mark Alan (SVP,Medical&Regulatory Affairs) Sale 7,000 60.76 425,285
2013-12-02 Goldberg Mark Alan (SVP,Medical&Regulatory Affairs) Option Ex 7,000 8.73 61,110
2013-11-18 Boess Carsten (SVP, Chief Financial Officer) Sale 9,927 55.54 551,295
2013-11-18 Boess Carsten (SVP, Chief Financial Officer) Option Ex 9,927 1.70 16,875
2013-11-01 Goldberg Mark Alan (SVP,Medical&Regulatory Affairs) Sale 7,000 50.33 352,310
2013-11-01 Goldberg Mark Alan (SVP,Medical&Regulatory Affairs) Option Ex 7,000 8.73 61,110
2013-10-01 Goldberg Mark Alan (SVP,Medical&Regulatory Affairs) Sale 7,000 64.29 450,030
2013-10-01 Goldberg Mark Alan (SVP,Medical&Regulatory Affairs) Option Ex 7,000 8.73 61,110
2013-09-25 14159, L.p. (Director) Buy 1,050,000 56.63 59,461,500
2013-09-25 Baker Felix (Director) Buy 1,050,000 56.63 59,461,500
2013-08-21 Boess Carsten (SVP, Chief Financial Officer) Sale 6,681 47.19 315,276
2013-08-21 Boess Carsten (SVP, Chief Financial Officer) Option Ex 6,681 23.00 153,663
2013-08-20 Boess Carsten (SVP, Chief Financial Officer) Sale 7,800 47.04 366,912
2013-08-20 Boess Carsten (SVP, Chief Financial Officer) Option Ex 7,800 12.35 96,330
2013-08-16 Boess Carsten (SVP, Chief Financial Officer) Sale 4,300 47.47 204,121
2013-08-16 Boess Carsten (SVP, Chief Financial Officer) Option Ex 4,300 1.70 7,310
2013-07-29 Patel Sanj K (President & CEO) Sale 15,895 47.39 753,264
2013-07-29 Patel Sanj K (President & CEO) Option Ex 15,895 3.52 55,950
2013-07-26 Patel Sanj K (President & CEO) Sale 69,394 48.11 3,338,545
2013-07-26 Patel Sanj K (President & CEO) Option Ex 52,190 2.61 136,215
2013-07-25 Patel Sanj K (President & CEO) Sale 14,711 48.73 716,867
2013-07-25 Patel Sanj K (President & CEO) Option Ex 31,915 1.20 38,298
2013-07-16 Heberlig Chris (Vice President, Finance) Sale 2,029 48.26 97,919
2013-07-15 Heberlig Chris (Vice President, Finance) Sale 495 49.15 24,329
2013-07-15 Heberlig Chris (Vice President, Finance) Option Ex 2,524 1.20 3,028
2013-07-11 Boess Carsten (SVP, Chief Financial Officer) Sale 13,237 47.06 622,933
2013-07-11 Boess Carsten (SVP, Chief Financial Officer) Option Ex 13,237 1.70 22,502
2013-06-12 Patel Sanj K (President & CEO) Sale 40,352 40.48 1,633,448
2013-06-12 Patel Sanj K (President & CEO) Option Ex 40,352 1.32 53,466
2013-06-11 Patel Sanj K (President & CEO) Sale 29,648 40.89 1,212,306
2013-06-11 Patel Sanj K (President & CEO) Option Ex 29,648 .95 28,165
2013-04-08 Patel Sanj K (President & CEO) Sale 21,695 49.49 1,073,685
2013-04-08 Patel Sanj K (President & CEO) Option Ex 21,695 .95 20,610
2013-04-05 Patel Sanj K (President & CEO) Sale 9,910 50.11 496,590
2013-04-05 Patel Sanj K (President & CEO) Option Ex 9,910 .95 9,414
2013-04-04 Patel Sanj K (President & CEO) Sale 21,931 50.83 1,114,686
2013-04-04 Patel Sanj K (President & CEO) Option Ex 21,931 .95 20,834
2013-04-03 Patel Sanj K (President & CEO) Sale 16,464 52.86 870,336
2013-04-03 Patel Sanj K (President & CEO) Option Ex 16,464 .95 15,640
2013-04-01 Goldberg Mark Alan (SVP,Medical&Regulatory Affairs) Sale 4,416 54.56 240,959
2013-04-01 Goldberg Mark Alan (SVP,Medical&Regulatory Affairs) Option Ex 4,416 .95 4,195
2013-03-01 Goldberg Mark Alan (SVP, Product Development) Sale 4,417 50.87 224,692
2013-03-01 Goldberg Mark Alan (SVP, Product Development) Option Ex 4,417 .95 4,196
2013-02-21 Patel Sanj K (President & CEO) Sale 45,392 49.02 2,225,115
2013-02-21 Patel Sanj K (President & CEO) Option Ex 45,392 .95 43,122
2013-02-20 Patel Sanj K (President & CEO) Sale 24,608 49.54 1,219,203
2013-02-20 Patel Sanj K (President & CEO) Option Ex 24,608 .95 23,377
2013-01-18 Quinn Anthony (SVP, Chief Medical Officer) Sale 9,447 50.08 473,105
2013-01-18 Quinn Anthony (SVP, Chief Medical Officer) Option Ex 9,447 .95 8,974
2013-01-17 Quinn Anthony (SVP, Chief Medical Officer) Sale 200 50.00 10,000
2013-01-17 Quinn Anthony (SVP, Chief Medical Officer) Option Ex 200 .95 190
2013-01-16 Quinn Anthony (SVP, Chief Medical Officer) Sale 5,353 50.07 268,024
2013-01-16 Quinn Anthony (SVP, Chief Medical Officer) Option Ex 353 .95 335
2013-01-16 Boess Carsten (SVP, Chief Financial Officer) Sale 9,927 49.12 487,614
2013-01-16 Boess Carsten (SVP, Chief Financial Officer) Option Ex 9,927 1.70 16,875
2013-01-09 Tisch Thomas J (Director) Buy 21,039 47.53 999,983
2013-01-04 14159, L.p. (Director) Buy 859,720 47.53 40,862,491
2013-01-04 Baker Felix (Director) Buy 859,720 47.53 40,862,491
2013-01-02 Goldberg Mark Alan (SVP, Product Development) Sale 4,417 47.52 209,895
2013-01-02 Goldberg Mark Alan (SVP, Product Development) Option Ex 4,417 .95 4,196
2012-12-19 Heberlig Chris (Vice President, Finance) Sale 4,000 45.95 183,800
2012-12-19 Heberlig Chris (Vice President, Finance) Option Ex 4,000 .95 3,800
2012-12-17 Patel Sanj K (President & CEO) Sale 32,319 46.84 1,513,918
2012-12-17 Patel Sanj K (President & CEO) Option Ex 32,319 .95 30,703
2012-12-14 Patel Sanj K (President & CEO) Sale 13,281 45.30 601,629
2012-12-14 Patel Sanj K (President & CEO) Option Ex 13,281 .95 12,616
2012-12-13 Patel Sanj K (President & CEO) Sale 14,400 46.02 662,688
2012-12-13 Patel Sanj K (President & CEO) Option Ex 14,400 .95 13,680
2012-12-05 Patel Sanj K (President & CEO) Sale 12,000 48.10 577,260
2012-12-05 Patel Sanj K (President & CEO) Option Ex 12,000 .95 11,400
2012-12-04 Patel Sanj K (President & CEO) Sale 23,000 49.34 1,134,843
2012-12-04 Patel Sanj K (President & CEO) Option Ex 23,000 .95 21,850
2012-12-03 Patel Sanj K (President & CEO) Sale 30,000 49.42 1,482,480
2012-12-03 Patel Sanj K (President & CEO) Option Ex 30,000 .95 28,500
2012-11-30 Patel Sanj K (President & CEO) Sale 5,000 48.86 244,325
2012-11-30 Patel Sanj K (President & CEO) Option Ex 5,000 .95 4,750
2012-10-17 Heberlig Chris (Vice President, Finance) Sale 4,000 49.66 198,620
2012-10-17 Heberlig Chris (Vice President, Finance) Option Ex 4,000 1.32 5,300
2012-10-16 Boess Carsten (SVP, Chief Financial Officer) Sale 9,927 50.54 501,740
2012-10-16 Boess Carsten (SVP, Chief Financial Officer) Option Ex 9,927 1.70 16,875
2012-09-04 Patel Sanj K (President & CEO) Sale 54,813 49.36 2,705,350
2012-09-04 Patel Sanj K (President & CEO) Option Ex 54,813 .95 52,072
2012-09-04 Heberlig Chris (Vice President, Finance) Sale 1,000 49.22 49,220
2012-09-04 Heberlig Chris (Vice President, Finance) Option Ex 1,000 .95 950
2012-08-31 Patel Sanj K (President & CEO) Sale 15,187 49.88 757,512
2012-08-31 Patel Sanj K (President & CEO) Option Ex 15,187 .95 14,427
2012-07-27 Quinn Anthony (SVP, Chief Medical Officer) Sale 6,400 50.24 321,504
2012-07-27 Quinn Anthony (SVP, Chief Medical Officer) Option Ex 6,400 .95 6,080
2012-07-26 Quinn Anthony (SVP, Chief Medical Officer) Sale 1,100 50.00 55,000
2012-07-26 Quinn Anthony (SVP, Chief Medical Officer) Option Ex 1,100 .95 1,045
2012-07-20 Quinn Anthony (SVP, Chief Medical Officer) Sale 600 50.00 30,000
2012-07-20 Quinn Anthony (SVP, Chief Medical Officer) Option Ex 600 .95 570
2012-07-19 Quinn Anthony (SVP, Chief Medical Officer) Sale 1,900 50.00 95,000
2012-07-19 Quinn Anthony (SVP, Chief Medical Officer) Option Ex 1,900 .95 1,805
2012-07-18 Boess Carsten (SVP, Chief Financial Officer) Sale 6,618 48.82 323,090
2012-07-18 Boess Carsten (SVP, Chief Financial Officer) Option Ex 6,618 1.70 11,250
2012-07-13 14159, L.p. (Director) Buy 886,000 41.20 36,503,200
2012-07-13 Baker Felix (Director) Buy 886,000 41.20 36,503,200
2012-07-12 Tisch Daniel R Sale 29,200 46.75 1,365,100
2012-07-12 Tisch Thomas J (Director) Buy 73,000 41.20 3,007,600
2012-07-11 Tisch Daniel R Sale 10,000 45.72 457,250
2012-07-10 Tisch Daniel R Sale 10,000 45.22 452,250
2012-06-27 Akkaraju Srinivas (Other) Sale 313,451 39.70 12,444,004
2012-06-26 Akkaraju Srinivas (Other) Sale 28,827 40.16 1,157,663
2012-06-25 Quinn Anthony (SVP, Chief Medical Officer) Sale 26,000 40.65 1,056,874
2012-06-04 Patel Sanj K (President & CEO) Sale 20,866 34.69 723,778
2012-06-04 Patel Sanj K (President & CEO) Option Ex 20,866 .95 19,822
2012-06-01 Patel Sanj K (President & CEO) Sale 29,134 35.83 1,043,929
2012-06-01 Patel Sanj K (President & CEO) Option Ex 29,134 .95 27,677
2012-06-01 Heberlig Chris (Vice President, Finance) Sale 1,000 36.00 35,996
2012-06-01 Heberlig Chris (Vice President, Finance) Option Ex 1,000 .95 950
2012-05-16 Boess Carsten (SVP, Chief Financial Officer) Sale 39,709 38.49 1,528,399
2012-05-16 Boess Carsten (SVP, Chief Financial Officer) Option Ex 39,709 1.70 67,505
2012-04-23 Tisch Daniel R Sale 3,000 40.10 120,300
2012-04-20 Tisch Daniel R Sale 10,000 39.66 396,599
2012-03-23 Patel Sanj K (President & CEO) Sale 50,000 33.53 1,676,400
2012-03-23 Patel Sanj K (President & CEO) Option Ex 50,000 .95 47,500
2012-03-19 Akkaraju Srinivas (Director) Sale 342,278 32.55 11,141,148
2012-02-29 Tisch Daniel R Sale 5,000 39.19 195,950
2012-02-27 Heberlig Chris (Vice President, Finance) Sale 4,500 36.88 165,960
2012-02-27 Heberlig Chris (Vice President, Finance) Option Ex 4,500 .95 4,275
2012-02-22 Tisch Daniel R Sale 2,118 38.90 82,390
2012-02-21 Tisch Daniel R Sale 942 38.90 36,643
2012-02-17 Tisch Daniel R Sale 9,190 38.50 353,815
2012-02-16 Tisch Daniel R Sale 15,750 38.01 598,657
2012-02-15 Tisch Daniel R Sale 24,481 37.34 914,120
2012-02-13 Tisch Daniel R Sale 61,262 36.20 2,217,684
2012-02-10 Tisch Daniel R Sale 582 35.70 20,777
2012-02-07 Tisch Daniel R Sale 884 35.50 31,382
2012-02-06 Tisch Daniel R Sale 5,716 35.62 203,603
2012-02-02 Tisch Daniel R Sale 100 35.50 3,550
2012-02-01 Tisch Daniel R Sale 9,975 35.50 354,112
2012-01-10 Tisch Thomas J Buy 1,200,000 25.18 30,216,000
2011-12-12 Malley Thomas (Director) Option Ex 13,200 2.24 29,502
2011-08-19 Edelman Joseph Sale 6,600 2.01 13,265
2011-08-18 Edelman Joseph Sale 1,500 2.11 3,165
2011-08-04 Edelman Joseph Buy 10,000 2.18 21,800
2011-08-03 Edelman Joseph Buy 70,000 2.22 155,610
2010-09-28 Baker Felix (Director) Buy 14,300 2.45 35,063
2009-10-08 Swiftcurrent Offshore Ltd. (10% Owner) Sale 2,136,858 3.53 7,551,656
2008-12-15 Tang Kevin C (Director) Sale 54,268 2.54 137,569
2008-03-17 Healey Joseph Patrick (Director) Buy 463,657 6.22 2,883,946
2007-10-01 Cohen Arthur Bruce (10% Owner) Buy 54,410 7.78 423,255
2007-09-28 Cohen Arthur Bruce (10% Owner) Buy 145,590 7.64 1,112,453
2007-09-27 Cohen Arthur Bruce (10% Owner) Buy 33,746 7.39 249,517
2007-09-21 Cohen Arthur Bruce (10% Owner) Buy 300,000 7.11 2,133,600
2007-08-22 Cohen Arthur Bruce (10% Owner) Buy 10,829 7.11 76,994
2007-08-21 Cohen Arthur Bruce (10% Owner) Buy 54,525 7.07 385,655
2007-08-21 Mignone Roberto (10% Owner) Buy 10,081 7.00 70,567
2007-08-20 Cohen Arthur Bruce (10% Owner) Buy 1,300 7.01 9,110
2007-08-20 Bridger Management Llc (10% Owner) Buy 31,893 7.07 225,483
2007-08-17 Cohen Arthur Bruce (10% Owner) Buy 9,600 7.01 67,324
2007-08-13 Cohen Arthur Bruce (10% Owner) Buy 184,905 6.95 1,285,459
2007-05-15 Ohmstede Carol (Other) Sale 5,616 7.14 40,098
2007-02-28 Bonczek Robert R (CFO and General Counsel) Option Ex 3,530 .34 1,200
2006-03-17 Bolognesi Dani P (Chief Scientific Officer) Option Ex 7,153 .34 2,432
2006-02-22 Bolognesi Dani P (Chief Scientific Officer) Sale 2,009 12.00 24,108
2006-02-22 Bolognesi Dani P (Chief Scientific Officer) Option Ex 2,009 .34 683
2006-01-25 Bolognesi Dani P (Chief Scientific Officer) Sale 3,060 11.30 34,578
2006-01-25 Bolognesi Dani P (Chief Scientific Officer) Option Ex 3,060 .34 1,040
2005-12-08 Crout J Richard (Director) Buy 300 12.00 3,598
2005-09-08 Tang Kevin C (Director) Buy 197,600 11.54 2,280,106

Insider trading activities including stock purchases, stock sales, and option exercises of GEVA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Trimeris Inc (symbol GEVA, CIK number 911326) see the Securities and Exchange Commission (SEC) website.